排序方式: 共有8条查询结果,搜索用时 0 毫秒
1
1.
AFD-Net: Apple Foliar Disease multi classification using deep learning on plant pathology dataset 总被引:2,自引:0,他引:2
Yadav Anju Thakur Udit Saxena Rahul Pal Vipin Bhateja Vikrant Lin Jerry Chun-Wei 《Plant and Soil》2022,477(1-2):595-611
Plant and Soil - Plant diseases significantly affect the crop, so their identification is very important. Correct identification of these diseases is crucial for establishing a good disease control... 相似文献
2.
Das B Rudra S Yadav A Ray A Rao AV Srinivas AS Soni A Saini S Shukla S Pandya M Bhateja P Malhotra S Mathur T Arora SK Rattan A Mehta A 《Bioorganic & medicinal chemistry letters》2005,15(19):4261-4267
Novel oxazolidinones were synthesized containing a number of substituted five-membered heterocycles attached to the 'piperazinyl-phenyl-oxazolidinone' core of eperezolid. Further, the piperazine ring of the core was replaced by other diamino-heterocycles. These modifications led to several compounds with potent activity against a spectrum of resistant and susceptible gram-positive organisms, along with the identification of ranbezolid (RBx 7644) as a clinical candidate. 相似文献
3.
4.
Jitendra A. Sattigeri Malvika Garg Pragya Bhateja Ajay Soni Abdul Rehman Abdul Rauf Mahendrakumar Gupta Mahesh S. Deshmukh Tarun Jain Nidhi Alekar Tarani Kanta Barman Paras Jha Tridib Chaira Ramesh B. Bambal Dilip J. Upadhyay Takahide Nishi 《Bioorganic & medicinal chemistry letters》2018,28(17):2993-2997
FimH is a type I fimbrial lectin located at the tip of type-1 pili of Gram-negative uropathogenic Escherichia coli (UPEC) guiding its ability to adhere and infect urothelial cells. Accordingly, blocking FimH with small molecule inhibitor is considered as a promising new therapeutic alternative to treat urinary tract infections caused by UPEC. Herein, we report that compounds having the S-glycosidic bond (thiomannosides) had improved metabolic stability and plasma exposures when dosed orally. Especially compound 5h showed the potential to inhibit biofilm formation and also to disrupt the preformed biofilm. And compound 5h showed prophylactic effect in UTI model in mice. 相似文献
5.
A Banerjee S Patil MY Pawar S Gullapalli PK Gupta MN Gandhi DK Bhateja M Bajpai RR Sangana GS Gudi N Khairatkar-Joshi LA Gharat 《Bioorganic & medicinal chemistry letters》2012,22(19):6286-6291
The synthesis and structure-activity relationship studies of a series of compounds from imidazopyridazinone scaffold as PDE7 inhibitors are disclosed. Potent analogs such as compounds 7 (31nM), 8 (27nM), and 9 (12nM) were identified. The PDE selectivity and pharmacokinetic profile of compounds 7, 8 and 9 are also disclosed. The adequate CNS penetration of compound 7 in mice allowed it to be tested in the MPTP induced PD model and haloperidol induced catalepsy model to probe the differential pharmacology of PDE7 in the striatal pathway. 相似文献
6.
Rudra S Sangita F Gujrati A Pandya M Bhateja P Mathur T Singhal S Rattan A Salman M Das B 《Bioorganic & medicinal chemistry letters》2007,17(17):4778-4783
Novel oxazolidinone derivatives of the lead compound RBx 8700, containing methylene oxygen- and methylene sulfur-linked substituents at the C5-position, were synthesized. Antibacterial screening of these compounds against a panel of resistant and susceptible Gram-positive and fastidious Gram-negative bacteria gave compounds 2 and 4 as new antibacterial agents. 相似文献
7.
Rudra S Yadav A Raja Rao AV Srinivas AS Pandya M Bhateja P Mathur T Malhotra S Rattan A Salman M Mehta A Cliffe IA Das B 《Bioorganic & medicinal chemistry letters》2007,17(24):6714-6719
Several potent oxazolidinone antibacterial agents were obtained by systematic modification of the linker between the five-membered heterocycle and the piperazinyl ring of RBx 7644 (Ranbezolid, 1) and its thienyl analogue 2, leading to the identification of an expanded spectrum compound RBx 8700 (6b). 相似文献
8.
Kumar R Rathy S Hajare AK Surase YB Dullu J Jadhav JS Venkataramanan R Chakrabarti A Pandya M Bhateja P Ramkumar G Das B 《Bioorganic & medicinal chemistry letters》2012,22(1):476-481
A novel series of acylides 4 were designed to overcome antibacterial resistance and evaluated for in vitro and in vivo activity. This series of acylides was designed from clarithromycin by changing the substitution on the desosamine nitrogen, followed by conversion to 3-O-acyl and 11,12-carbamate. These compounds showed significantly potent antibacterial activity against not only Gram-positive pathogens, including macrolide-lincosamide-streptogramin B (MLS(B))-resistant and efflux-resistant strains, but also Gram-negative pathogens such as Haemophilus influenzae. These acylides also showed better activity against telithromycin resistant Streptococcus pneumoniae strains. 相似文献
1